Subscribe

Approaches to Alleviating Costs for Patients and Payers

VBCC - Media Library - Pricing
Andrew Stainthorpe, PhD

The cost of oncology products can be ameliorated, to some extent, for payers and patients, by using imaginative reimbursement approaches. Some may involve risk shares. Some may involve other managed entry schemes that pay by outcomes. Those can help with the burden of cost for patients and payers.

Related Items
Benefits of the Single Payer Perspective
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Payer-Provider
Weighing Cost and Care: An Oncologist's Debate
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Personalized Medicine
Bringing the Patient into the Conversation
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Personalized Medicine
Using Research to Guide Quality and Quantity of Care
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Personalized Medicine
Affordability + Clinical Effectiveness = The Value Equation
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Providing Patients with Cost Information
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
New Conversations About Costs of Cancer Care
C. Daniel Mullins, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Keeping Cost Out of the Drug Approval Debate
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Value-Based Concerns of European Oncologists
Andrew Stainthorpe, PhD
VBCC - Media Library published on March 25, 2015 in Pricing
Value-Based Concerns - What Matters?
Linda Bosserman, MD, FACP
VBCC - Media Library published on March 25, 2015 in Pricing
Last modified: September 29, 2015
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology